DAL vs EBS
Delta Air Lines Inc (DAL) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DAL and EBS stock pages for the full models.
Not investment advice.